WeVote
Log In

Bill

Bill

HB 2392

JAIL RELEASE-OPIOID ANTAGONIST

104th Regular Session Introduced by Lindsey LaPointe

Illinois bill requiring jails to distribute opioid antagonists (naloxone) to releases to reduce overdose deaths among formerly incarcerated individuals.

Rule 19(a) / Re-referred to Rules Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 2392

Legislative bill overview

HB 2392 would require Illinois correctional facilities to provide opioid antagonists (such as naloxone/Narcan) to incarcerated individuals upon their release from jail. The bill aims to reduce overdose deaths among formerly incarcerated people, who face elevated overdose risk due to reduced opioid tolerance after incarceration.

Why is this important

Formerly incarcerated individuals experience overdose death rates significantly higher than the general population in the critical period immediately following release. Providing naloxone at release creates a direct harm-reduction intervention that could prevent fatal overdoses during this high-risk transition period.

Potential points of contention

  • Cost and implementation: Funding requirements for purchasing and distributing naloxone across all Illinois jails, plus staff training on administration
  • Liability concerns: Questions about whether facilities face legal responsibility if naloxone is misused or if overdose occurs despite distribution
  • Scope limitations: Bill doesn't address broader reentry support (treatment access, housing, employment), raising questions about whether naloxone alone addresses root causes

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.